Literature DB >> 16870419

Immunogenomics of unrelated hematopoietic cell transplantation.

Effie W Petersdorf1.   

Abstract

The MHC on human chromosome 6p21 encodes the HLA genes that govern histocompatibility in transplantation. Selection of potential unrelated volunteer donors for hematopoietic cell transplantation has required an understanding of the role of HLA gene products in mediating graft-versus-host and host-versus-graft alloreactions that give rise to the 'transplantation barrier'. Recent advances in the immunogenomics of the MHC in unrelated hematopoietic cell transplantation have been made through systemic examination of the alleles and antigens of large populations of racially and ethnically diverse transplant donors and recipients. The importance of non-HLA MHC-resident genetic variation in clinical outcome is increasingly being recognized. These data show that clinical outcome following transplantation is shaped by the combined effects of many genes within the MHC and their sequence polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870419     DOI: 10.1016/j.coi.2006.07.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  5 in total

1.  Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.

Authors:  Yasuo Morishima; Takakazu Kawase; Mari Malkki; Satoko Morishima; Stephen Spellman; Koichi Kashiwase; Shunichi Kato; Anne Cesbron; Jean-Marie Tiercy; David Senitzer; Andrea Velardi; Effie W Petersdorf
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-06       Impact factor: 5.742

2.  Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype.

Authors:  Kyoko Sugimoto; Makoto Murata; Makoto Onizuka; Yoshihiro Inamoto; Seitaro Terakura; Yachiyo Kuwatsuka; Taku Oba; Koichi Miyamura; Yoshihisa Kodera; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-03-26       Impact factor: 2.490

3.  Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.

Authors:  Carrie L Kitko; Sophie Paczesny; Gregory Yanik; Thomas Braun; Dawn Jones; Joel Whitfield; Sung W Choi; Raymond J Hutchinson; James L M Ferrara; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

Review 4.  Pathophysiology of acute graft-versus-host disease: recent advances.

Authors:  Yaping Sun; Isao Tawara; Tomomi Toubai; Pavan Reddy
Journal:  Transl Res       Date:  2007-07-03       Impact factor: 7.012

Review 5.  Acute graft versus host disease.

Authors:  David A Jacobsohn; Georgia B Vogelsang
Journal:  Orphanet J Rare Dis       Date:  2007-09-04       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.